CG Oncology CGON
NASDAQ CGON
$62.58 +0.65 (+1.05%)
As of: Oct 21, 2026 · 11:41 AM EDT

CG Oncology (CGON) Debt Ratio (2025 - 2026)

Updated

CG Oncology's Debt Ratio came in at 0.00 for Q2 2026, up 4.6% from the prior quarter.

Analysis

CG Oncology (CGON) Debt Ratio (2025 - 2026) Analysis & Trends

Going back to Q3 2025, CG Oncology's Debt Ratio data covers 4 quarters.

  • The five-year range for quarterly Debt Ratio is 0.00 (Q1 2026) to 0.00 (Q3 2025).
  • Business Quant data shows CGON's Debt Ratio at 0.00 (Q1 2026), 0.00 (Q4 2025) and 0.00 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 0.39
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 0.24
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 0.52
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 0.42
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 0.08
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 0.28
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 0.60
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 0.53
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 0.31
10 CG Oncology 5.53 Bn 2.00 Bn -2.77 Mn 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
API Access

CG Oncology Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CGON&period=max&api_key=YOUR_API_KEY